Kallikreins, DPPIV (dipeptidyl peptidase IV), FAP (fibroblast activation protein) and PEP (prolyl endopeptidase) serine proteases are all crucial players in cancer, emerging as clinical markers and prospective diagnostic targets [61]. This evidence concerns the gene PREP and cancer.